R
Remo H.M. Furtado
Researcher at University of São Paulo
Publications - 68
Citations - 5110
Remo H.M. Furtado is an academic researcher from University of São Paulo. The author has contributed to research in topics: Medicine & Myocardial infarction. The author has an hindex of 14, co-authored 49 publications receiving 3121 citations. Previous affiliations of Remo H.M. Furtado include Brigham and Women's Hospital & Albert Einstein Hospital.
Papers
More filters
Journal ArticleDOI
Aos pacientes com coronariopatia aguda, apenas a dosagem inicial de troponina é o melhor que temos a oferecer?
TL;DR: El importante trabajo de Santos et al1 viene a contribuir a un mejor entendimiento del tema, al analizar el papel de the troponina and of the CKMB masa en una población no seleccionada of pacientes con cuadro clínico compatible with coronariopatía aguda.
Journal ArticleDOI
Permanent pacemaker implantation in a pregnant woman with rheumatic mitral valve disease
Rodrigo Barbosa Esper,Remo H.M. Furtado,Flávio Tarasoutchi,Guilherme Sobreira Spina,Max Grinberg,Walkiria Samuel Avila +5 more
TL;DR: A rare case of permanent pacemaker implantation in a pregnant woman with rheumatic mitral valve disease previously undergoing percutaneous balloon valvuloplasty and presented symptomatic advanced atrioventricular block of non-reversible cause.
Journal ArticleDOI
Implante de marcapaso definitivo en gestante portadora de valvulopatía mitral reumática
Rodrigo Barbosa Esper,Remo H.M. Furtado,Flávio Tarasoutchi,Guilherme Sobreira Spina,Max Grinberg,Walkiria Samuel Avila +5 more
TL;DR: In this paper, un caso raro de implante de marcapaso definitivo en gestante, portadora de valvulopatia mitral reumatica, previamente sometida a valvulooplastia percutanea por cateter balon, presentaba bloqueo atrioventricular en grado avanzado, de causa irreversible, sintomatico and manifiesto in el 3o trimestre de gestacion.
Journal ArticleDOI
P2Y12 inhibitor monotherapy versus dual antiplatelet therapy in patients with acute coronary syndromes undergoing coronary stenting: rationale and design of the NEOMINDSET Trial.
Patrícia O. Guimarães,Marcelo Franken,Caio A.M. Tavares,Fábio Serra Silveira,Murillo de Oliveira Antunes,R. Bergó,Rodrigo de Moura Joaquim,Pedro Beraldo de Andrade,Fabio G Pitta,José Mariani,Bruno Ramos Nascimento,J. Eduardo T. de Paula,M. S. Silveira,Tibério Augusto Oliveira Costa,F. T. C. Dall’Orto,Renato Giestas Serpa,Louis Nakayama Ohe,Fernanda Mangione,Remo H.M. Furtado,Rogério Sarmento-Leite,Frederico Monfardini,Silvia R.L. Assis,Jose C. Nicolau,Andrei C. Sposito,Renato D. Lopes,Yoshinobu Onuma,Marco Valgimigli,Dominick J. Angiolillo,Patrick W. Serruys,Otavio Berwanger,Fernando Bacal,Pedro A. Lemos +31 more
TL;DR: The NEOMINDSET trial as mentioned in this paper compared SAPT versus DAPT in 3,400 acute coronary syndromes (ACS) patients undergoing PCI with the latest-generation drug-eluting stents (DES).